Tech Company Financing Transactions
Mnemosyne Pharmaceuticals Funding Round
Mnemosyne Pharmaceuticals, based in Cambridge, scored investment capital from Slater Technology Fund.
Transaction Overview
Company Name
Announced On
6/28/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Initial funding will support the founders in recruiting a world-class scientific advisory board, in prosecuting initial patent filings, and in corporate/business development and fund-raising.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
The company is a Providence-based drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vanessa King
Chief Scientific Officer
Tim Piser
Vice President
Robert Volkmann
VP - Operations
David Anderson
Browse more venture capital transactions:
Prev: 6/28/2010: Vigilistics venture capital transaction
Next: 6/28/2010: Novelion Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs